Anavex Life Sciences Corp. (AVXL) vs Neuronetics, Inc. (STIM)

A side-by-side comparison of Anavex Life Sciences Corp. and Neuronetics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AVXL vs STIM

growth of $100 · dividends reinvested · last 8y
AVXL -50.0% (-8.3%/yr)STIM -92.1% (-27.2%/yr)AVXL compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $1002020202220242026$50$8
AVXL STIM

AVXL vs STIM: by the numbers

  • •STIM is the larger company ($154M vs $149M market cap).
  • •Both run net losses; AVXL's is the smaller (0.00% vs -19.62% net margin).

Metrics side by side

Valuation

MetricAVXLSTIM
P/S ratioN/A0.99
P/B ratio1.328.64

Profitability

MetricAVXLSTIM
Gross margin0.00%49.12%
Operating margin0.00%-14.74%
Net margin0.00%-19.62%
ROE-21.38%-170.49%
ROIC-27.25%-22.15%

Growth (annualized)

MetricAVXLSTIM
Revenue CAGR (5Y)N/A23.26%
Total return CAGR (5Y)-37.74%-19.46%

Frequently asked

How have AVXL and STIM total returns compared?
Over the past 5 years, AVXL delivered -37.74% and STIM delivered -19.46% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.